171 related articles for article (PubMed ID: 33049330)
21. A sequential delivery system employing the synergism of EPO and NGF promotes sciatic nerve repair.
Zhang W; Zhou G; Gao Y; Zhou Y; Liu J; Zhang L; Long A; Zhang L; Tang P
Colloids Surf B Biointerfaces; 2017 Nov; 159():327-336. PubMed ID: 28806665
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
Morlock M; Kissel T; Li YX; Koll H; Winter G
J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
[TBL] [Abstract][Full Text] [Related]
23. Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in mice.
Chen G; Deng H; Song X; Lu M; Zhao L; Xia S; You G; Zhao J; Zhang Y; Dong A; Zhou H
Biomaterials; 2017 Nov; 144():30-41. PubMed ID: 28820966
[TBL] [Abstract][Full Text] [Related]
24. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
[TBL] [Abstract][Full Text] [Related]
25. [Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression].
Jehle T; Meschede W; Dersch R; Feltgen N; Bach M; Lagrèze WA
Ophthalmologe; 2010 Apr; 107(4):347-53. PubMed ID: 19787355
[TBL] [Abstract][Full Text] [Related]
26. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization.
Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD
Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157
[TBL] [Abstract][Full Text] [Related]
27. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemia.
Chen YS; Green CR; Wang K; Danesh-Meyer HV; Rupenthal ID
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):378-86. PubMed ID: 25497487
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse.
Rex TS; Wong Y; Kodali K; Merry S
Exp Eye Res; 2009 Nov; 89(5):735-40. PubMed ID: 19591826
[TBL] [Abstract][Full Text] [Related]
29. Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.
Kim J; Lima E Silva R; Shmueli RB; Mirando AC; Tzeng SY; Pandey NB; Ben-Akiva E; Popel AS; Campochiaro PA; Green JJ
Acta Biomater; 2019 Oct; 97():451-460. PubMed ID: 31374338
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal injection worsens outcomes in a mouse model of indirect traumatic optic neuropathy from closed globe injury.
Naguib S; Bernardo-Colón A; Rex TS
Exp Eye Res; 2021 Jan; 202():108369. PubMed ID: 33238184
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin reduces nerve demyelination, neuropathic pain behavior and microglial MAPKs activation through erythropoietin receptors on Schwann cells in a rat model of peripheral neuropathy.
Huang CT; Chen SH; Lin SC; Chen WT; Lue JH; Tsai YJ
Glia; 2018 Nov; 66(11):2299-2315. PubMed ID: 30417431
[TBL] [Abstract][Full Text] [Related]
32. [Therapeutic effects and related mechanisms of erythropoietin sustained-release gelatin hydrogel microspheres on a murine model of hindlimb ischemia].
Xiao JW; Li LH; Hong BZ; Xiao JQ; Wei DM; Jin Z
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):524-9. PubMed ID: 27346267
[TBL] [Abstract][Full Text] [Related]
33. Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of human erythropoietin.
Fares F; Ganem S; Hajouj T; Agai E
Endocrinology; 2007 Oct; 148(10):5081-7. PubMed ID: 17641000
[TBL] [Abstract][Full Text] [Related]
34. Drug-Free ROS Sponge Polymeric Microspheres Reduce Tissue Damage from Ischemic and Mechanical Injury.
O'Grady KP; Kavanaugh TE; Cho H; Ye H; Gupta MK; Madonna MC; Lee J; O'Brien CM; Skala MC; Hasty KA; Duvall CL
ACS Biomater Sci Eng; 2018 Apr; 4(4):1251-1264. PubMed ID: 30349873
[TBL] [Abstract][Full Text] [Related]
35. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
36. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
Kavas A; Keskin D; Altunbaş K; Tezcaner A
Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor.
Xiong Y; Mahmood A; Qu C; Kazmi H; Zhang ZG; Noguchi CT; Schallert T; Chopp M
J Neurotrauma; 2010 Jan; 27(1):205-15. PubMed ID: 19715391
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study.
Kashkouli MB; Pakdel F; Sanjari MS; Haghighi A; Nojomi M; Homaee MH; Heirati A
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):731-6. PubMed ID: 20890611
[TBL] [Abstract][Full Text] [Related]
39. Microparticle Depots for Controlled and Sustained Release of Endosomolytic Nanoparticles.
Garland KM; Sevimli S; Kilchrist KV; Duvall CL; Cook RS; Wilson JT
Cell Mol Bioeng; 2019 Oct; 12(5):429-442. PubMed ID: 31719925
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection.
King CE; Rodger J; Bartlett C; Esmaili T; Dunlop SA; Beazley LD
Exp Neurol; 2007 May; 205(1):48-55. PubMed ID: 17328893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
